Kenzo Uzu

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Possible mechanism of late lumen enlargement after treatment for de novo coronary lesions with drug-coated balloon

Tetsuya Yamamoto, Takahiro Sawada, Kenzo Uzu et al. · International Journal of Cardiology · 2020 · 82 citations · Full text

Medicine, Cardiology, Clinical Sciences +16

Association between daily glucose fluctuation and coronary plaque properties in patients receiving adequate lipid-lowering therapy assessed by continuous glucose monitoring and optical coherence tomography

Masaru Kuroda, Toshiro Shinke, Kazuhiko Sakaguchi et al. · Cardiovascular Diabetology · 2015 · 46 citations · Full text

Medicine, Cardiology, Biomedical Imaging +16

Impact of CD14 ++ CD16 + monocytes on coronary plaque vulnerability assessed by optical coherence tomography in coronary artery disease patients

Hiroyuki Yamamoto, Naofumi Yoshida, Toshiro Shinke et al. · Atherosclerosis · 2018 · 45 citations

Medicine, Cardiology, Clinical Sciences +16

Effects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomography

Masaru Kuroda, Toshiro Shinke, Hiromasa Otake et al. · Cardiovascular Diabetology · 2016 · 44 citations · Full text

Medicine, Cardiology, Biomedical Imaging +16